Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Role of Sphingolipids in AcuTE Respiratory Distress Syndrome

NCT03654352 is registered in ClinicalTrials.gov with Sturgill as lead sponsor.

NCT NCT03654352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03654352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Role of Sphingolipids in AcuTE Respiratory Distress Syndrome
Lead sponsor
Sturgill
Phase
Observational
Overall status
Completed
Start date
April 17, 2019
Completion date
March 12, 2021
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury, acute respiratory distress syndrome